NumerixS Investment Technologies’s Clovis Oncology, Inc. CLVS Stock Holding History

NumerixS Investment Technologies’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-10,072	Closed	-$105K	–	1356
2019 Q4	$105K	Buy	+10,072	New	+$73.2K	0.02%	663
2019 Q2	–	Sell	-2,550	Closed	-$62K	–	1424
2019 Q1	$62K	Buy	+2,550	New	+$63.9K	0.01%	961
2018 Q4	–	Sell	-8,500	Closed	-$252K	–	1471
2018 Q3	$252K	Buy	+8,500	New	+$329K	0.05%	504
2017 Q2	–	Sell	-8,200	Closed	-$522K	–	1408
2017 Q1	$522K	Buy	+8,200	New	+$498K	0.06%	398

Other funds holding CLVS

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

NumerixS Investment Technologies's CLVS Position: Q1 2020 in Review

NumerixS Investment Technologies sold out of Clovis Oncology, Inc. (CLVS) in Q1 2020, closing a stake of 10,072 shares — an estimated $105K sold.

NumerixS Investment Technologies first reported a position in CLVS in Q1 2017 and held it in 4 quarters. The position peaked at $522K in Q1 2017. 154 funds tracked by Wall St. Rank hold CLVS as of Q1 2020.

NumerixS Investment Technologies reported no remaining Clovis Oncology, Inc. position as of Q1 2020 after selling out during the quarter.
NumerixS Investment Technologies sold 10,072 Clovis Oncology, Inc. shares in Q1 2020, an estimated $105K.
NumerixS Investment Technologies first reported a position in Clovis Oncology, Inc. in Q1 2017 and held it in 4 quarters.
NumerixS Investment Technologies's Clovis Oncology, Inc. position peaked at $522K in Q1 2017.
154 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2020.

Based on NumerixS Investment Technologies's 13F filing for Q1 2020, filed 15 May 2020.